Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular diseasePaola Dongiovanni, Luca Valenti, Jan Borén et al.|Hepatology|2014Cited by 529
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic SteatohepatitisLuca Valenti, Silvia Fargion|Diabetes|2008Cited by 188
Iron Depletion by Deferoxamine Up-Regulates Glucose Uptake and Insulin Signaling in Hepatoma Cells and in Rat LiverPaola Dongiovanni, Silvia Fargion|American Journal Of Pathology|2008Cited by 164
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Luca Valenti, Guido Baselli et al.|Scientific Reports|2019Cited by 123